Releaf Blog
Discover helpful insights on health, wellness, and medical cannabis in our blogs. Explore practical articles covering general medical cannabis info, tips for staying well, and how medical cannabis can assist with specific health conditions.
Latest
A year of listening: how our patients shaped Releaf in 2025
Over the past year, more than 50 patients chose to share their stories with Releaf. Taken together, those experiences shaped how we listened, learned, and supported people throughout 2025. This reflection brings together five patient voices that echo many of the challenges and moments we heard across the year, and how those voices continue to shape the way we care, communicate, and build support around our patients.
How long does cannabis stay in your system?
Cannabis stays in your system for anywhere between three and 90 days. There are multiple factors that will influence if cannabis is detectable in the body including the type of test, the method of ingestion, the dose, and the tested individuals metabolism. Tests are designed to show the presence of THC or THC metabolites depending on the type of sample being analysed. Having THC or traces of past use of THC in your system does not imply you are impaired. Let’s take a look in more detail to understand the nuance.
National stress day: Exploring stress management with medical cannabis
The 1st of November 2023 is an important day for many in the medical cannabis community, because it marks five years of its legalisation in the UK. But, what you may not have known is that November the 1st is also the day dedicated to raising awareness of stress – a condition medical cannabis has shown potential in alleviating.
Five years since legislation: A comprehensive overview of UK medical cannabis
In this article, we will analyse some key insights and statistics relating to patient access and experiences with medical cannabis, as well as discussing changes in public perceptions and awareness, and medical cannabis research that has taken place since 2018. We’ll also explore the economic impact of medical cannabis by analysing the facts and figures available, and recap regulatory changes that have taken place, whilst shedding light on the challenges that may be coming in the future.
Three’s not a crowd: CBPMs should be digitally prescribed, say The Home Office, NHS England, and The ACMD
Two weeks ago, Chris Philp MP revealed he is in support of the proposals made by NHS England and the Advisory Council for the Misuse of Drugs (ACMD), that would allow for the electronic prescription of schedule 2 and schedule 3 drugs.